Embryonic Stem Cells for Osteo-Degenerative Diseases

Methods in Molecular Biology

Volumn 690, Issue , 2010, Pages 1-30

  Nieden, Nicole I zur ^a,b  

^a FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Embryonic stem cell; Immunological rejection; Osteo degenerative disease; Skeletal injury; Teratoma; Transplantation

Indexed keywords

ANIMALIA;

ANIMAL; BONE; BONE DISEASE; CARTILAGE; CYTOLOGY; EMBRYONIC STEM CELL; HUMAN; PATHOLOGY; PRENATAL DEVELOPMENT; REVIEW; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TRANSPLANTATION;

ANIMALS; BONE AND BONES; BONE DISEASES; CARTILAGE; EMBRYONIC STEM CELLS; HUMANS; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 84858189125     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-962-8_1     Document Type: Chapter

References (191)

1. National Osteoporosis Foundation. http://www.nof.org/osteoporosis/diseasefacts. htm.
2. Kovacic, J.C., Muller, D.W., Harvey, R., and Graham, R.M. (2005) Update on the use of stem cells for cardiac disease. Intern. Med. J. 35(6), 348–356.
3. Feron, F., Perry, C., Cochrane, J., Licina, P., Nowitzke, A., Urquhart, S., et al. (2005) Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain 128(Pt 12), 2951–2960.
4. Freed, C.R., Greene, P.E., Breeze, R.E., Tsai, W.Y., DuMouchel, W., Kao, R., et al. (2001) Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. N. Engl. J. Med. 344(10), 710–719.
5. Bachoud-Levi, A.C., Gaura, V., Brugieres, P., Lefaucheur, J.P., Boisse, M.F., Maison, P., et al. (2006) Effect of fetal neural transplants in patients with Huntington’s disease 6 years after surgery: a long-term follow-up study. Lancet Neurol. 5(4), 303–309.
6. Farkas, G., and Karacsonyi, S. (1985) Clinical transplantation of fetal human pancreatic islets. Biomed. Biochim. Acta 44(1), 155–159.
7. Le Blanc, K., Gotherstrom, C., Ringden, O., Hassan, M., McMahon, R., Horwitz, E., et al. (2005). Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 79(11), 1607–1614.
8. Tuch, B.E. (2006) Stem cells – a clinical update. Aust. Fam. Physician 35(9), 719–721.
9. Takahashi, K., and Yamanaka, S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4), 663–676.
10. Okita, K., Ichisaka, T., and Yamanaka, S. (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448(7151), 313–317.
11. Aasen, T., Raya, A., Barrero, M.J., Garreta, E., Consiglio, A., Gonzalez, F., et al. (2009) Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 26(11), 1276–1284.
12. Ryan, M.C., and Sandell, L.J. (1990) Differential expression of a cysteine-rich domain in the NH2-terminal propeptide of type II (cartilage) procollagen. J. Biol. Chem. 265, 10334–10339.
13. Eyre, D.R., Weis, M.A., and Wu, J.J. (2006) Articular cartilage collagen: an irreplaceable framework? Eur. Cell Mater. 12, 57–63.
14. Eyre, D. (2004) Collagen of articular cartilage. Arthritis Res. 4(1), 30–35.
15. Heinegard, D., and Paulsson, M. (1984) Structure and metabolism of proteoglycans. In: Piez, K.A., Reddi, A.H. (eds). Extracellular matrix biochemistry. Elsevier, New York, p. 277.
16. Termine, J.D., and Robey, P.G. (1996) Bone matrix proteins and the mineralization process. In: Favus MJ (ed). Primer on the metabolic bone diseases and disorders of mineral metabolism. Lippincott-Raven, Philadelphia, pp. 24–28.
17. Aubin, J.E., Liu, F., Malaval, L., and Gupta, A.K. (1995) Osteoblast and chond-roblast differentiation. Bone 17(2 Suppl), 77S–83S.
18. Davies JE (1996). In vitro modeling of the bone/implant interface. Anat. Rec. 245(2), 426–445.
19. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A.L., and Karsenty, G. (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89(5), 747–754.
20. Harada, H., Tagashira, S., Fujiwara, M., Ogawa, S., Katsumata, T., Yamaguchi, A., et al. (1999) Cbfa1 isoforms exert functional differences in osteoblast differentiation. J. Biol. Chem. 274(11), 6972–6978.
21. Kern, B., Shen, J., Starbuck, M., and Karsenty, G. (2001) Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes. J. Biol. Chem. 276(10), 7101–7107.
22. Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J.M., Behringer, R.R., et al. (2002) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108, 17–29.
23. Tanaka, S., Takahashi, N., Udagawa, N., Tamura, T., Akatsu, T., Stanley, E.R., et al. (1993) Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J. Clin. Invest. 91(1), 257–263.
24. Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S., et al. (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclasto-genesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95(7), 3597–3602.
25. Lacey, D.L., Timms, E., Tan, H.L., Kelley, M.J., Dunstan, C.R., Burgess, T., et al. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93(2), 165–176.
26. Doetschmann, T.C., Eistetter, H., Katz, M., Schmidt, W., and Kemler, R. (1985) The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 87, 27–45.
27. Olsen, B.R., Reginato, A.M., and Wang, W. (2000) Bone development. Annu. Rev. Cell. Dev. Biol. 16, 191–220.
28. Karsenty, G., and Wagner, E.F. (2002) Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2(4), 389–406.
29. Yang, X., and Karsenty, G. (2002) Transcription factors in bone: developmental and pathological aspects. Trends Mol. Med. 8(7), 340–345.
30. Vu, T.H., Shipley, J.M., Bergers, G., Berger, J.E., Helms, J.A., Hanahan, D., et al. (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93(3), 411–422.
31. Ducy, P., Starbuck, M., Priemel, M., Shen, J., Pinero, G., Geoffroy, V., et al. (1999) A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 13(8), 1025–1036.
32. Hjelmeland, A.B., Schilling, S.H., Guo, X., Quarles, D., and Wang, X.F. (2005) Loss of Smad3-mediated negative regulation of Runx2 activity leads to an alteration in cell fate determination. Mol. Cell. Biol. 25(21), 9460–9468.
33. Ogawa, E., Maruyama, M., Kagoshima, H., Inuzuka, M., Lu, J., Satake, M., et al. (1993) PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc. Natl. Acad. Sci. USA 90(14), 6859–6863.
34. Xiao, Z.S., Thomas, R., Hinson, T.K., and Quarles, L.D. (1998) Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor. Gene 214, 187–197.
35. Pozner, A., Goldenberg, D., Negreanu, V., Le, S.Y., Elroy-Stein, O., Levanon, D., et al. (2000) Transcription-coupled translation control of AML1/RUNX1 is mediated by cap-and internal ribosome entry site-dependent mechanisms. Mol. Cell. Biol. 20, 2297–2307.
36. Drissi, H., Luc, Q., Shakoori, R., Chuva, De Sousa Lopes, S., Choi, J.Y., et al. (2000) Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene. J. Cell. Physiol. 184(3), 341–350.
37. Stewart, M., Terry, A., Hu, M., O’Hara, M., Blyth, K., Baxter, E., et al. (1997) Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene. Proc. Natl. Acad. Sci. USA 94(16), 8646–8651.
38. Thirunavukkarasu, K., Mahajan, M., McLarren, K.W., Stifani, S., and Karsenty, G. (1998) Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfbeta. Mol. Cell. Biol. 18, 4197–4208.
39. Banerjee, C., Javed, A., Choi, J.-Y., Green, J., Rosen, V., Van Wijnen, A.J., et al. (2001) Differential regulation of the two principal Runx2/Cbfa1 N-Terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype. Endocrinology 142(9), 4026–4039
40. Javed, A., Guo, B., Hiebert, S., Choi, J.Y., Green, J., Zhao, S.C., et al. (2000). Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/PEBP2(alpha)) dependent activation of tissue-specific gene transcription. J. Cell Sci. 113(Pt 12), 2221–2231.
41. Javed, A., Barnes, G.L., Jasanya, B.O., Stein, J.L., Gerstenfeld, L., Lian, J.B., et al. (2001) runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: evidence for promoter context-dependent activity of Cbfa proteins. Mol. Cell. Biol. 21(8), 2891–2905.
42. Gao, Y.H., Shinki, T., Yuasa, T., Kataoka-Enomoto, H., Komori, T., Suda, T., et al. (1998) Potential role of cbfa1, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis: regulation of mRNA expression of osteoclast differentiation factor (ODF). Biochem. Biophys. Res. Commun. 252(3), 697–702.
43. Philipsen, S., and Suske, G.A. (1999) Tale of three fingers: the family of mammalian Sp/ XKLF transcription factors. Nucleic Acids Res. 27, 2991–3000.
44. Black, A.R., Black, J.D., and Azizkhan-Clifford, J. (2001) Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J. Cell. Physiol. 188, 143–160.
45. Göllner, H., Dani, C., Phillips, B., Philipsen, S., and Suske, G. (2001) Impaired ossification in mice lacking the transcription factor Sp3. Mech. Dev. 106, 77–83.
46. Milona, M.A., Gough, J.E., and Edgar, A.J. (2003) Expression of alternatively spliced isoforms of human Sp7 in osteoblast-like cells. BMC Genomics 4(1), 43.
47. Nishio, Y., Dong, Y., Paris, M., O’Keefe, R.J., Schwarz, E.M., and Drissi, H. (2006) Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene. Gene 372, 62–70.
48. Maehata, Y., Takamizawa, S., Ozawa, S., Kato, Y., Sato, S., Kubota, E., et al. (2006) Both direct and collagen-mediated signals are required for active vitamin D3-elicited differentiation of human osteoblastic cells: roles of osterix, an osteoblast-related transcription factor. Matrix Biol. 25(1), 47–58.
49. Shen, Q., and Christakos, S. (2005) The vitamin D receptor, Runx2, and the Notch signaling pathway cooperate in the transcriptional regulation of osteopontin. J. Biol. Chem. 280(49), 40589–40598.
50. Xiao, Z.S., Hinson, T.K., and Quarles, L.D. (1999) Cbfa1 isoform overexpression upreg-ulates osteocalcin gene expression in non-osteoblastic and pre-osteoblastic cells. J. Cell. Biochem. 74(4), 596–605.
51. McClellan, J.W., Mulconrey, D.S., Forbes, R.J., and Fullmer, N. (2006) Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2). J. Spinal Disord. Tech. 19(7), 483–486.
52. Vaidya, R., Weir, R., Sethi, A., Meisterling, S., Hakeos, W., and Wybo, C.D. (2007) Interbody fusion with allograft and rhBMP-2 leads to consistent fusion but early subsidence. J. Bone Joint Surg. Br. 89(3), 342–345.
53. Choi, K.Y., Kim, H.J., Lee, M.H., Kwon, T.G., Nah, H.D., Furuichi, T., et al. (2005) Runx2 regulates FGF2-induced Bmp2 expression during cranial bone development. Dev. Dyn. 233(1), 115–121.
54. Zehentner, B.K., Dony, C., and Burtscher, H. (1999) The transcription factor Sox9 is involved in BMP-2 signaling. J. Bone Miner. Res. 14(10), 1734–1741.
55. Chimal-Monroy, J., Rodriguez-Leon, J., Montero, J.A., Ganan, Y., Macias, D., Merino, R., et al. (2003) Analysis of the molecular cascade responsible for mesodermal limb chondrogenesis: Sox genes and BMP signaling. Dev. Biol. 257(2), 292–301.
56. Lefebvre, V., and de Crombrugghe, B. (1998) Toward understanding SOX9 function in chondrocyte differentiation. Matrix Biol. 16(9), 529–540.
57. Smits, P., Li, P., Mandel, J., Zhang, Z., Deng, J.M., Behringer, R.R., et al. (2001) The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev. Cell 1(2), 277–290.
58. Akiyama, H., Chaboissier, M.C., Martin, J.F., Schedl, A., and de Crombrugghe, B. (2002) The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 16(21), 2813–2828.
59. Lefebvre, V., Behringer, R.R., and de Crombrugghe, B. (2001) L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway. Osteoarthritis Cartilage 9(Suppl A), S69–S75.
60. Bi, W., Deng, J.M., Zhang, Z., Behringer, R.R., and de Crombrugghe, B. (1999) Sox9 is required for cartilage formation. Nat. Genet. 22(1), 85–89.
61. Boyle, W.J., Simonet, W.S., and Lacey, D.L. (2003) Osteoclast differentiation and activation. Nature 423(6937), 337–342.
62. Lanzi, R., Losa, M., Villa, I., Gatti, E., Sirtori, M., Dal Fiume, C., et al. (2003) GH replacement therapy increases plasma osteoprotegerin levels in GH-deficient adults. Eur. J. Endocrinol. 148(2), 185–191.
63. Kwon, O.H., Lee, C.K., Lee, Y.I., Paik, S.G., and Lee, H.J. (2005) The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors. Biochem. Biophys. Res. Commun. 335(2), 437–446.
64. Xing, L., Bushnell, T.P., Carlson, L., Tai, Z., Tondravi, M., Siebenlist, U., et al. (2002) NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK-and cytokine-mediated osteoclastogenesis. J. Bone Miner. Res. 17(7), 1200–1210.
65. Kuroki, Y., Shiozawa, S., Sugimoto, T., Kanatani, M., Kaji, H., Miyachi, A., et al. (1994) Constitutive c-fos expression in osteoblastic MC3T3-E1 cells stimulates osteoclast maturation and osteoclastic bone resorption. Clin. Exp. Immunol. 95(3), 536–539.
66. Grigoriadis, A.E., Wang, Z.Q., Cecchini, M.G., Hofstetter, W., Felix, R., Fleisch, H.A., et al. (1994) c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science. 266(5184), 443–448.
67. Yamane, T., Kunisada, T., Yamazaki, H., Nakano, T., Orkin, S.H., and Hayashi, S.I. (2000) Sequential requirements for SCL/ tal-1, GATA-2, macrophage colony-stimulating factor, and osteoclast differentiation factor/osteoprotegerin ligand in osteoclast development. Exp. Hematol. 28(7), 833–840.
68. Lindunger, A., MacKay, C.A., Ek-Rylander, B., Andersson, G., and Marks, S.C. Jr. (1990) Histochemistry and biochemistry of tartrate-resistant acid phosphatase (TRAP) and tartrate-resistant acid adenosine triphosphatase (TrATPase) in bone, bone marrow and spleen: implications for osteoclast ontogeny. Bone Miner. 10(2), 109–119.
69. Bossard, M.J., Tomaszek, T.A., Thompson, S.K., Amegadzie, B.Y., Hanning, C.R., Jones, C., et al. (1996) Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification. J. Biol. Chem. 271(21), 12517–12524.
70. Itskovitz-Eldor, J., Schuldiner, M., Karsenti, D., Eden, A., Yanuka, O., Amit, M., et al. (2000) Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol. Med. 6(2), 88–95.
71. Gerecht-Nir, S., Cohen, S., and Itskovitz-Eldor, J. (2004) Bioreactor cultivation enhances the efficiency of human embryoid body (hEB) formation and differentiation. Biotechnol. Bioeng. 86(5), 493–502.
72. zur Nieden, N.I., Kempka, G., and Ahr, H.J. (2003). In vitro differentiation of embryonic stem cells into mineralized osteoblasts. Differentiation 71(1), 18–27.
73. zur Nieden, N.I., Kempka, G., Rancourt, D.E., and Ahr, H.J. (2005) Induction of chondro-, osteo-and adipogenesis in embryonic stem cells by bone morphogenetic protein-2: effect of cofactors on differentiating lineages. BMC Dev. Biol. 5(1), 1.
74. zur Nieden, N.I., Cormier, J.T., Rancourt, D.E., and Kallos, M.S. (2007) Embryonic stem cells remain highly pluripotent following long term expansion as aggregates in suspension bioreactors. J. Biotechnol. 129(3), 421–432.
75. Yamane, T., Kunisada, T., Yamazaki, H., Era, T., Nakano, T., and Hayashi, S.I. (1997) Development of osteoclasts from embryonic stem cells through a pathway that is c-fms but not c-kit dependent. Blood 90(9), 3516–35123.
76. Evans, M.J., and Kaufman, M.H. (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292(5819), 154–156.
77. Martin, G.R. (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 78(12), 7634–7638.
78. Doetschman, T., Williams, P., and Maeda, N. (1998) Establishment of hamster blastocyst-derived embryonic stem (ES) cells. Dev. Biol. 127(1), 224–227.
79. Iannaccone, P.M., Taborn, G.U., Garton, R.L., Caplice, M.D., and Brenin, D.R. (1994) Pluripotent embryonic stem cells from the rat are capable of producing chimeras. Dev. Biol. 163(1), 288–292.
80. Giles, J.R., Yang, X., Mark, W., and Foote, R.H. (1993) Pluripotency of cultured rabbit inner cell mass cells detected by isozyme analysis and eye pigmentation of fetuses following injection into blastocysts or morulae. Mol. Reprod. Dev. 36(2), 130–138.
81. Graves, K.H., and Moreadith, R.W. (1993) Derivation and characterization of putative pluripotential embryonic stem cells from preimplantation rabbit embryos. Mol. Reprod. Dev. 36(4), 424–433.
82. Sims, M., and First, N.L. (1994) Production of calves by transfer of nuclei from cultured inner cell mass cells. Proc. Natl. Acad. Sci. USA 91(13), 6143–6147.
83. Thomson, J.A., Kalishman, J., Golos, T.G., Durning, M., Harris, C.P., Becker, R.A., et al. (1995) Isolation of a primate embryonic stem cell line. Proc. Natl. Acad. Sci. USA 92(17), 7844–7848.
84. Thomson, J.A., Kalishman, J., Golos, T.G., Durning, M., Harris, C.P., and Hearn, J.P. (1996) Pluripotent cell lines derived from common marmoset (Callithrix jacchus) blastocysts. Biol. Reprod. 55(2), 254–259.
85. Sasaki, E., Hanazawa, K., Kurita, R., Akatsuka, A., Yoshizaki, T., Ishii, H., et al. (2005) Establishment of novel embryonic stem cell lines derived from the common marmoset (Callithrix jacchus). Stem Cells 23(9), 1304–1313.
86. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S., et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282(5391), 1145–1147.
87. Reubinoff, B.E., Pera, M.F., Fong, C.Y., Trounson, A., and Bongso, A. (2000) Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 18(4), 399–404.
88. Amit, M., and Itskovitz-Eldor, J. (2002) Derivation and spontaneous differentiation of human embryonic stem cells. J. Anat. 200(Pt 3), 225–232.
89. Maltsev, V.A., Rohwedel, J., Hescheler, J., and Wobus, A.M. (1993). Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types. Mech. Dev. 44(1), 41–50.
90. Klug, M.G., Soonpaa, M.H., Koh, G.Y., and Field, L.J. (1996) Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J. Clin. Invest. 98(1), 216–224.
91. Soria, B., Roche, E., Berná, G., León-Quinto, T., Reig, J.A., and Martín, F. (2000) Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 49(2), 157–162.
92. Hamazaki, T., Iiboshi, Y., Oka, M., Papst, P.J., Meacham, A.M., Zon, L.I., et al. (2001) Hepatic maturation in differentiating embryonic stem cells in vitro. FEBS Lett. 497(1), 15–19.
93. Okabe, S., Forsberg-Nilsson, K., Spiro, A.C., Segal, M., and McKay, R.D. (1996) Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro. Mech. Dev. 59(1), 89–102.
94. Keller, G., Kennedy, M., Papayannopoulou, T., and Wiles, M.V. (1993) Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol. Cell. Biol. 13(1), 473–486.
95. Kramer, J., Hegert, C., Guan, K., Wobus, A.M., Müller, P.K., and Rohwedel, J. (2000) Embryonic stem cell-derived chondrogenic differentiation in vitro: activation by BMP-2 and BMP-4. Mech. Dev. 92(2), 193–205.
96. Assady, S., Maor, G., Amit, M., Itskovitz-Eldor, J., Skorecki, K. L., and Tzukerman, M. (2001) Insulin production by human embryonic stem cells. Diabetes 50(8), 1691–1697.
97. Kehat, I., Kenyagin-Karsenti, D., Snir, M., Segev, H., Amit, M., Gepstein, A., et al. (2001) Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 108(3), 407–414.
98. Kaufman, D.S., Hanson, E.T., Lewis, R.L., Auerbach, R., and Thomson, J.A. (2001) Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 98(19), 10716–10721.
99. Smith, A.G. (2001) Embryo-derived stem cells: of mice and men. Annu. Rev. Cell Dev. Biol. 17, 435–462.
100. Smith, A.G., Heath, J.K., Donaldson, D.D., Wong, G.G., Moreau, J., Stahl, M., et al. (1988) Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336(6200), 688–690.
101. Williams, R.L., Hilton, D.J., Pease, S., Willson, T.A., Stewart, C.L., Gearing, D.P., et al. (1988) Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336(6200), 684–687.
102. Nichols, J., Evans, E.P., and Smith, A.G. (1990) Establishment of germ-line-compe-tent embryonic stem (ES) cells using differentiation inhibiting activity. Development 110(4), 1341–1348.
103. Metcalf, D. (1990) The induction and inhibition of differentiation in normal and leu-kaemic cells. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 327(1239), 99–109.
104. Nichols, J., Zevnik, B., Anastassiadis, K., Niwa, H., Klewe-Nebenius, D., Chambers, I., et al. (1998) Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95(3), 379–391.
105. Palmieri, S.L., Peter, W., Hess, H., and Schöler, H.R. (1994) Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in implantation. Dev. Biol. 166(1), 259–267.
106. Rosner M.H., Vigano M.A., Ozato K., Timmons P.M., Poirier F., Rigby P.W., et al. (1990) A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 345(6277), 686–692.
107. Schöler, H.R., Dressler, G.R., Balling, R., Rohdewohld, H., and Gruss, P. (1990) Oct-4: a germline-specific transcription factor mapping to the mouse t-complex. EMBO J. 9(7), 2185–2195.
108. Schöler, H.R., Ruppert, S., Suzuki, N., Chowdhury, K., and Gruss, P. (1990) New type of POU domain in germ line-specific protein Oct-4. Nature 344(6265), 435–439.
109. Niwa, H., Miyazaki, J., and Smith, A.G. (2000) Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24(4), 372–376.
110. Avilion, A.A., Nicolis, S.K., Pevny, L.H., Perez, L., Vivian, N., and Lovell-Badge, R. (2003) Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 17(1), 126–140.
111. Mitsui, K., Tokuzawa, Y., Itoh, H., Segawa, K., Murakami, M., Takahashi, K., et al. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113(5), 631–642.
112. Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S., et al. (2003) Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113(5), 643–655.
113. Tomioka, M., Nishimoto, M., Miyagi, S., Katayanagi, T., Fukui, N., Niwa, H., et al. (2002). Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex. Nucleic Acids Res. 30(14), 3202–3213.
114. Chew, J.-L., Loh, Y.-H., Zhang, W., Chen, X., Tam, W.-L., Yeap, L.-S., et al. (2005) Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Mol. Cell. Biol. 25(14), 6031–6046.
115. Okumura-Nakanishi, S., Saito, M., Niwa, H., and Ishikawa, F. (2005) Oct-3/4 and Sox2 regulate Oct-3/4 gene in embryonic stem cells. J. Biol. Chem. 280(7), 5307–5317.
116. Kuroda, T., Tada, M., Kubota, H., Kimura, H., Hatano, S.Y., Suemori, H., et al. (2005). Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol. Cell. Biol. 25(6), 2475–2485
117. Rodda, D.J., Chew, J.L., Lim, L.H., Loh, Y.H., Wang, B., Ng, H.H., et al. (2005) Transcriptional regulation of nanog by OCT4 and SOX2. J. Biol. Chem. 280(26), 24731–24737.
118. Boyer, L.A., Lee, T.I., Cole, M.F., Johnstone, S.E., Levine, S.S., Zucker, J.P., et al. (2005) Core transcriptional regulatory circuitry in human embryonic stem cells. Cell. 122(6), 947–956.
119. Bernstein, B.E., Kamal, M., Lindblad-Toh, K., Bekiranov, S., Bailey, D.K., Huebert, D.J., et al. (2005). Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120(2), 169–181.
120. Azuara, V., Perry, P., Sauer, S., Spivakov, M., Jørgensen, H.F., John, R.M., et al. (2006) Chromatin signatures of pluripotent cell lines. Nat. Cell Biol. 8(5), 532–538.
121. Kirmizis, A., Bartley, S.M., Kuzmichev, A., Margueron, R., Reinberg, D., Green, R., et al. (2004) Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. Genes Dev. 18(13), 1592–1605.
122. Boyer, L.A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L.A., Lee T.I., et al. (2006) Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441(7091), 349–353.
123. Wang, H., Wang, L., Erdjument-Bromage, H., Vidal, M., Tempst, P., Jones, R.S., et al. (2004) Role of histone H2A ubiquitination in Polycomb silencing. Nature 431(7010), 873–878.
124. Schwartz, Y.B., and Pirrotta, V. (2007) Polycomb silencing mechanisms and the management of genomic programmes. Nat. Rev. Genet. 8(1), 9–22.
125. Wittrant, Y., Theoleyre, S., Couillaud, S., Dunstan, C., Heymann, D., and Rédini, F. (2004) Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities. Exp. Cell Res. 293(2), 292–301.
126. Tsuneto, M., Yamazaki, H., Yoshino, M., Yamada, T., and Hayashi, S. (2005) Ascorbic acid promotes osteoclastogenesis from embryonic stem cells. Biochem. Biophys. Res. Commun. 335(4), 1239–1246.
127. Okuyama, H., Tsuneto, M., Yamane, T., Yamazaki, H., and Hayashi, S. (2003) Discrete types of osteoclast precursors can be generated from embryonic stem cells. Stem Cells 21(6), 670–680.
128. Hemmi, H., Okuyama, H., Yamane, T., Nishikawa, S., Nakano, T., Yamazaki, H., et al. (2001) Temporal and spatial localization of osteoclasts in colonies from embryonic stem cells. Biochem. Biophys. Res. Commun. 280(2), 526–534.
129. Hayashi, S., Yamane, T., Miyamoto, A., Hemmi, H., Tagaya, H., Tanio, Y., et al. (1998) Commitment and differentiation of stem cells to the osteoclast lineage. Biochem. Cell Biol. 76(6), 911–922.
130. Porcher, C., Swat, W., Rockwell, K., Fujiwara, Y., Alt, F.W., and Orkin, S.H. (1996) The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell 86(1), 47–57.
131. Elefanty, A.G., Robb, L., Birner, R., and Begley, C.G. (1997) Hematopoietic-specific genes are not induced during in vitro differentiation of scl-null embryonic stem cells. Blood 90(4), 1435–1447.
132. Tsuneto, M., Tominaga, A., Yamazaki, H., Yoshino, M., Orkin, S.H., and Hayashi, S. (2005). Enforced expression of PU.1 rescues osteoclastogenesis from embryonic stem cells lacking Tal-1. Stem Cells 23(1), 134–143.
133. Cao, T., Heng, B.C., Ye, C.P., Liu, H., Toh, W.S., Robson, P., et al. (2005) Osteogenic differentiation within intact human embryoid bodies result in a marked increase in osteocalcin secretion after 12 days of in vitro culture, and formation of distinct nodule-structure. Tissue Cell. 37(4), 325–34.
134. Yao, S., Chen, S., Clark, J., Hao, E., Beattie, G.M., Hayek, A., et al. (2006) Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. Proc. Natl. Acad. Sci. USA 103(18), 6907–6912.
135. Beddington, R.S., Rashbass, P., Wilson, V. (1992) Brachyury – a gene affecting mouse gastrulation and early organogenesis. Dev. Suppl. 157–165.
136. Gadue, P., Huber, T.L., Paddison, P.J., Keller, G.M. (2006) Wnt and TGF-beta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells. Proc. Natl. Acad. Sci. USA 103(45), 16806–16811.
137. Nakanishi, M., Kurisaki, A., Hayashi, Y., Warashina, M., Ishiura, S., Kusuda-Furue, M., et al. (2009) Directed induction of anterior and posterior primitive streak by Wnt from embryonic stem cells cultured in a chemically defined serum-free medium. FASEB J. 23(1), 114–122.
138. Phillips, B.W., Belmonte, N., Vernochet, C., Ailhaud, G., and Dani, C. (2001) Compactin enhances osteogenesis in murine embryonic stem cells. Biochem. Biophys. Res. Commun. 284(2), 478–484.
139. Buttery LD, Bourne S, Xynos JD, Wood H, Hughes FJ, Hughes SP, et al. (2001) Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells. Tissue Eng. 7(1), 89–99.
140. Ahn, S.E., Kim, S., Park, K.H., Moon, S.H., Lee, H.J., Kim, G.J., et al. (2006) Primary bone-derived cells induce osteogenic differentiation without exogenous factors in human embryonic stem cells. Biochem. Biophys. Res. Commun. 340, 403–408.
141. Hwang, Y.S., Randle, W.L., Bielby, R.C., Polak, J.M., and Mantalaris, A. (2006) Enhanced derivation of osteogenic cells from murine embryonic stem cells after treatment with hepG2-conditioned medium and modulation of the embryoid body formation period: application to skeletal tissue engineering. Tissue Eng. 12, 1381–1392.
142. Davis, L.A., and zur Nieden, N.I. (2008) Mesodermal fate decisions of a stem cell: the Wnt switch. Cell. Mol. Life Sci. 65(17), 2658–2674.
143. Sottile, V., Thomson, A., and McWhir, J. (2003) In vitro osteogenic differentiation of human ES cells. Cloning Stem Cells 5, 149–155.
144. Bielby, R.C., Boccaccini, A.R., Polak, J.M., and Buttery, L.D. (2004) In vitro differentiation and in vivo mineralization of osteogenic cells derived from human embryonic stem cells. Tissue Eng. 10(9–10), 1518–1525.
145. Yamashita, A., Takada, T., Narita, J., Yamamoto, G., and Torii, R. (2005) Osteoblastic differentiation of monkey embryonic stem cells in vitro. Cloning Stem Cells 7, 232–237.
146. zur Nieden, N.I., Price, F.D., Davis, L.A., Everitt, R.E., Rancourt, D.E. (2007) Gene profiling on mixed embryonic stem cell populations reveals a biphasic role for beta-catenin in osteogenic differentiation. Mol. Endocrinol. 21(3), 674–685.
147. Krishnan, V., Bryant, H.U., and Macdougald, O.A. (2006) Regulation of bone mass by Wnt signaling. J. Clin. Invest. 116(5), 1202–1209.
148. Gong, Y., Slee, R.B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A.M., et al. (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107(4), 513–523.
149. Bain, G., Muller, T., Wang, X., and Papkoff, J. (2003) Activated beta-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction. Biochem. Biophys. Res. Commun. 301(1), 84–91.
150. Tolwinski, N.S., and Wieschaus, E. (2004) A nuclear escort for beta-catenin. Nat. Cell Biol. 6(7), 579–580.
151. van de Wetering, M., Cavallo, R., Dooijes, D., van Beest, M., van Es, J., Loureiro, J., et al. (1997) Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88(6), 789–799.
152. Behrens, J., von Kries, J.P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R., et al. (1996) Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382(6592), 638–642.
153. Topol, L., Jiang, X., Choi, H., Garrett-Beal, L., Carolan, P.J., and Yang, Y. (2003) Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J. Cell. Biol. 162(5), 899–908.
154. Gaur, T., Lengner, C.J., Hovhannisyan, H., Bhat, R.A., Bodine, P.V., Komm, B.S., et al. (2005) Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J. Biol. Chem. 280(39), 33132–33140.
155. Schinke, T., and Karsenty, G. (1999) Characterization of Osf1, an osteoblast-specific transcription factor binding to a critical cis-acting element in the mouse Osteocalcin promoters. J. Biol. Chem. 274(42), 30182–30189.
156. Kolpakova, E., and Olsen, B.R. (2005) Wnt/ beta-catenin – a canonical tale of cell-fate choice in the vertebrate skeleton. Dev. Cell. 8(5), 626–627.
157. Day, T.F., Guo, X., Garrett-Beal, L., and Yang, Y. (2005) Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell. 8(5), 739–750.
158. Vats, A., Bielby, R.C., Tolley, N., Dickinson, S.C., Boccaccini, A.R., Hollander, A.P., et al. (2006) Chondrogenic differentiation of human embryonic stem cells: the effect of the micro-environment. Tissue Eng. 12(6), 1687–1697.
159. Sui, Y., Clarke, T., and Khillan, J.S. (2003) Limb bud progenitor cells induce differentiation of pluripotent embryonic stem cells into chondrogenic lineage. Differentiation 71, 578–585.
160. Cserjesi, P., Brown, D., Ligon, K.L., Lyons, G.E., Copeland, N.G., Gilbert, D.J., et al. (1995) Scleraxis: a basic helix-loop-helix protein that prefigures skeletal formation during mouse embryogenesis. Development 121(4), 1099–1110.
161. Toh, W.S., Yang, Z., Liu, H., Heng, B.C., Lee, E.H., and Cao, T. (2007) Effects of culture conditions and bone morphogenetic protein 2 on extent of chondrogenesis from human embryonic stem cells. Stem Cells 25(4), 950–960.
162. Hegert, C., Kramer, J., Hargus, G., Muller, J., Guan, K., Wobus, A.M., et al. (2002) Differentiation plasticity of chondrocytes derived from mouse embryonic stem cells. J. Cell Sci. 115(Pt 23), 4617–4628.
163. Ikeda, T., Kamekura, S., Mabuchi, A., Kou, I., Seki, S., Takato, T., et al. (2004) The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum. 50(11), 3561–3573.
164. Kim, I.S., Otto, F., Zabel, B., and Mundlos, S. (1999) Regulation of chondrocyte differentiation by Cbfa1. Mech. Dev. 80, 159–170.
165. Wright, E., Hargrave, M.R., Christiansen, J., Cooper, L., Kun, J., Evans, T., et al. (1995) The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos. Nat. Genet. 9, 15–20.
166. Barberi, T., Willis, L.M., Socci, N.D., and Studer, L. (2005). Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med. 2(6), e161.
167. Trivedi, P., and Hematti, P. (2007) Simultaneous generation of CD34+ primitive hematopoietic cells and CD73+ mesenchymal stem cells from human embryonic stem cells cocultured with murine OP9 stromal cells. Exp. Hematol. 35(1), 146–154.
168. Trivedi, P., and Hematti, P. (2008) Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Exp. Hematol. 36(3), 350–359.
169. Arpornmaeklong, P., Brown, S.E., Wang, Z., Krebsbach, P.H. (2009) Phenotypic characterization, osteoblastic differentiation, and bone regeneration capacity of human embryonic stem cell-derived mesenchymal stem cells. Stem Cells Dev. 18(7), 955–968.
170. Olivier, E.N., Rybicki, A.C., and Bouhassira, E.E. (2006) Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells. Stem Cells 24(8), 1914–1922.
171. Hwang, N.S., Varghese, S., Lee, H.J., Zhang, Z., Ye, Z., Bae, J., et al. (2008) In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc. Natl. Acad. Sci. USA 105(52), 20641–20646.
172. Lian, Q., Lye, E., Suan Yeo, K., Khia Way Tan, E., Salto-Tellez, M., Liu, T.M., et al. (2007) Derivation of clinically compliant MSCs from CD105+, CD24-differentiated human ESCs. Stem Cells 25(2), 425–436.
173. Brederlau, A., Correia, A.S., Anisimov, S.V., Elmi, M., Paul, G., Roybon, L., et al. (2006) Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson’s disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells 24(6), 1433–1440.
174. Taiani, J., Krawetz, R.J., zur Nieden, N.I., Wu, E.Y., Kallos, M.S., Matyas, J.R., Rancourt, D.E. (2010) Reduced differentiation efficiency of murine embryonic stem cells in stirred suspension bioreactors. Stem Cells Dev. 19(7), 989–998.
175. Wakitani, S., Takaoka, K., Hattori, T., Miyazawa, N., Iwanaga, T., Takeda, S., et al. (2003) Embryonic stem cells injected into the mouse knee joint form teratomas and subsequently destroy the joint. Rheumatology 42(1), 162–165.
176. Wakitani, S., Aoki, H., Harada, Y., Sonobe, M., Morita, Y., Mu, Y., et al. (2004) Embryonic stem cells form articular cartilage, not teratomas, in osteochondral defects of rat joints. Cell. Transplant. 13(4), 331–336.
177. Nakajima, M., Wakitani, S., Harada, Y., Tanigami, A., and Tomita, N. (2007) In vivo mechanical condition plays an important role for appearance of cartilage tissue in ES cell transplanted joint. J. Orthop. Res. 26(1), 10–17.
178. Nussbaum, J., Minami, E., Laflamme, M.A., Virag, J.A., Ware, C.B., Masino, A., et al. (2007) Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J. 21(7), 1345–1357.
179. Swijnenburg, R.J., Tanaka, M., Vogel, H., Baker, J., Kofidis, T., Gunawan, F., et al. (2005) Embryonic stem cell immunogenic-ity increases upon differentiation after transplantation into ischemic myocardium. Circulation 112(9 Suppl), I166–I172.
180. Lee, S.J., Lim, G.J., Lee, J.-W., Atala, A., and Yoo, J.J. (2006) In vitro evaluation of a poly(lactide-co-glycolide)–collagen composite scaffold for bone regeneration. Biomaterials 27(18), 3466–3472.
181. Kim, S., Kim, S.S., Lee, S.H., Eun Ahn, S., Gwak, S.J., Song, J.H., et al. (2008) In vivo bone formation from human embryonic stem cell-derived osteogenic cells in poly(d,l-lactic-co-glycolic acid)/hydroxyap-atite composite scaffolds. Biomaterials 29(8), 1043–1053.
182. Hwang, N.S., Varghese, S., and Elisseeff, J. (2008) Derivation of chondrogenically-com-mitted cells from human embryonic cells for cartilage tissue regeneration. PLoS One 3(6), e2498.
183. Webster, W.S., Johnston, M.C., Lammer, E.J., and Sulik, K.K. (1986) Isotretinoin embryopathy and the cranial neural crest: an in vivo and in vitro study. J. Craniofac. Genet. Dev. Biol. 6(3), 211–222.
184. Zhou, Y., and Snead, M.L. (2008) Derivation of cranial neural crest-like cells from human embryonic stem cells. Biochem. Biophys. Res. Commun. 376(3), 542–547.
185. Borello, U., Buffa, V., Sonnino, C., Melchionna, R., Vivarelli, E., and Cossu, G. (1999) Differential expression of the Wnt putative receptors Frizzled during mouse somitogenesis. Mech. Dev. 89(1–2), 173–177.
186. Kimura, Y., Matsunami, H., Takeichi, M. (1996) Expression of cadherin-11 delineates boundaries, neuromeres, and nuclei in the developing mouse brain. Dev. Dyn. 206(4), 455–462.
187. Hoffmann, I., and Balling, R. (1995) Cloning and expression analysis of a novel mesodermally expressed cadherin. Dev. Biol. 169(1), 337–346.
188. Lee, G., Kim, H., Elkabetz, Y., Al Shamy, G., Panagiotakos, G., Barberi, T., et al. (2007) Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nat. Biotechnol. 25(12), 1468–1475.
189. Kimura, Y., Matsunami, H., Inoue, T., Shimamura, K., Uchida, N., Ueno, T., et al. (1995) Cadherin-11 expressed in association with mesenchymal morphogenesis in the head, somite, and limb bud of early mouse embryos. Dev. Biol. 169(1), 347–358.
190. Jukes, J.M., Both, S.K., Leusink, A., Sterk, L.M., van Blitterswijk, C.A., and de Boer, J. (2008) Endochondral bone tissue engineering using embryonic stem cells. Proc. Natl. Acad. Sci. USA 105(19), 6840–6845.
191. Billon, N., Iannarelli, P., Monteiro, M.C., Glavieux-Pardanaud, C., Richardson, W.D., Kessaris, N., et al. (2007) The generation of adipocytes by the neural crest. Development 134(12), 2283–2292.